Medical News

RSS
Kona Medical closes Series D equity financing of $10 million

Kona Medical closes Series D equity financing of $10 million

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

Personalis launches early access program to Personalis ACE Clinical Exome

Personalis launches early access program to Personalis ACE Clinical Exome

Cardiome signs agreement with Algorithm to sell, distribute BRINAVESS

Cardiome signs agreement with Algorithm to sell, distribute BRINAVESS

Research paper published by Scientific Reports details the efficacy of n3D's Apple iPhone app

Research paper published by Scientific Reports details the efficacy of n3D's Apple iPhone app

Arthritis Society launches campaign to urge Canadians to speak up, "Share The Pain"

Arthritis Society launches campaign to urge Canadians to speak up, "Share The Pain"

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

DOH releases SPHHS study investigating prescribing of antipsychotics to District seniors

DOH releases SPHHS study investigating prescribing of antipsychotics to District seniors

Verastem presents positive results from VS-6063 clinical and preclinical studies at 2013 AACR-NCI-EORTC meeting

Verastem presents positive results from VS-6063 clinical and preclinical studies at 2013 AACR-NCI-EORTC meeting

UCLA study uncovers biological clock that may shed light on why our bodies age

UCLA study uncovers biological clock that may shed light on why our bodies age

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

First Edition: October 21, 2013

First Edition: October 21, 2013

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

WebMD signs agreement to repurchase all shares from Icahn Group

WebMD signs agreement to repurchase all shares from Icahn Group

Medical Cannabis Payment Systems announces marketing features for S2S Seed-to-Sale solution

Medical Cannabis Payment Systems announces marketing features for S2S Seed-to-Sale solution

CSHL researchers explore how the brain integrates multiple signals to identify one unique smell

CSHL researchers explore how the brain integrates multiple signals to identify one unique smell

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.